Has John Harding, MD received payments from drug or device companies?

Yes. Drug and device makers reported $5,543 in general payments to John Harding, MD across 209 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Harding, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Harding, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Harding, MD

Obstetrics & Gynecology · Salem, VANPI 1457318776

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,200 of the $5,543 with a category attached, or 75.8%. 33 manufacturers reported payments, led by Intuitive Surgical at 26.2% of the total. 2025 is the largest year on record at $1,543, 4.5 times the $342 reported in 2019. Among obstetrics & gynecology clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,543in general payments, 2019–2025

Across 209 payments — averaging $26.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Intuitive Surgical$1K
AbbVie$562
Exeltis, USA Inc.$456
Amgen$442
Bayer$404
Minerva Surgical, Inc$362
plus $2K from 27 others

What the payments were for

Travel & lodging$1,31224%
Food & beverage$4,20076%
Education$311%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Intuitive Surgical	9	$1,451
AbbVie(2 entities)	26	$562
Exeltis, USA Inc.	25	$456
Amgen	20	$442
Bayer	24	$404
Minerva Surgical, Inc	4	$362
Travere Therapeutics, Inc.	20	$360
Organon	12	$276
Novo Nordisk	14	$225
Mayne Pharma Commercial LLC	4	$84
Vifor Pharma, Inc.	4	$78
Biogen	4	$70
Convatec Inc.	3	$66
Hologic Sales And Service, LLC	4	$65
Astellas Pharma US Inc	4	$61
Tactile Systems Technology Inc	1	$56
Therapeuticsmd, Inc.	4	$50
Vertex	2	$47
Merck	3	$47
Avion Pharmaceuticals	3	$47
Pfizer	2	$40
Coopersurgical, Inc.	1	$35
AstraZeneca	2	$34
AMAG Pharmaceuticals, Inc.	2	$31
Otsuka America Pharmaceutical, Inc.	2	$30
Abbott	2	$30
Evofem Biosciences, Inc.	2	$27
Aspira Women's Health Inc	1	$25
Mallinckrodt Hospital Products Inc.	1	$20
Daiichi Sankyo Inc.	1	$18
Medtronic	1	$17
Sumitomo Pharma America, Inc.	1	$14
LSI Solutions Inc	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,543 in reported general payments places this provider in the 90th percentile of 992 obstetrics & gynecology providers in Virginia.

See all obstetrics & gynecology providers in Virginia →

Medicare billing

Part B allowed, 2024

$150,587

Medicare patients

128

Services billed

6,006

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Estradiol	14	$1,210
Megestrol Acetate	13	$196
Clobetasol Propionate	15	$184
Metronidazole	26	$151
Fluconazole	21	$116
Ibuprofen	13	$53

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Salem

Joseph TroiseSalem$144K
Thomas KimbleNorfolk$286K
Jack AyoubLeesburg$279K
Kurian ThottStafford$216K
Nina SmithHarrisonburg$199K
Bunan AlnaifChesapeake$139K
James JonesRichmond$134K
Melissa DelgadoVienna$95K
Joann PinkertonCharlottesville$35K
Kristin SchraaMechanicsville$35K

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →